Integrated Advisors Network’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $279K | Buy |
5,067
+1,067
| +27% | +$58.7K | 0.01% | 638 |
|
|
2025
Q1 | $283K | Buy |
4,000
+876
| +28% | +$61.9K | 0.01% | 594 |
|
|
2024
Q4 | $205K | Sell |
3,124
-2,138
| -41% | -$141K | 0.01% | 663 |
|
|
2024
Q3 | $370K | Buy |
5,262
+1,876
| +55% | +$132K | 0.02% | 541 |
|
|
2024
Q2 | $279K | Sell |
3,386
-53
| -2% | -$4.36K | 0.01% | 579 |
|
|
2024
Q1 | $300K | Sell |
3,439
-94
| -3% | -$8.21K | 0.02% | 588 |
|
|
2023
Q4 | $341K | Buy |
3,533
+206
| +6% | +$19.9K | 0.02% | 522 |
|
|
2023
Q3 | $294K | Buy |
3,327
+25
| +0.8% | +$2.21K | 0.02% | 536 |
|
|
2023
Q2 | $286K | Hold |
3,302
| – | – | 0.02% | 556 |
|
|
2023
Q1 | $321K | Buy |
3,302
+130
| +4% | +$12.6K | 0.02% | 530 |
|
|
2022
Q4 | $328K | Buy |
+3,172
| New | +$328K | 0.02% | 497 |
|